RTSL Stock: Rapid Therapeutic Science Laboratories, Inc. Stock Price, Analysis & Insights
Get live RTSL stock price $0.00, comprehensive Rapid Therapeutic Science Laboratories, Inc. stock analysis, charts, news, and expert forecast. Real-time RTSL stock data and investment insights.
Loading chart data...
Rapid Therapeutic Science Laboratories, Inc. (RTSL) Overview
Rapid Therapeutic Science Laboratories, Inc. (RTSL) is a publicly traded company in the Healthcare sector , specifically within the Medical - Devices industry . As of the latest trading session, RTSL trades at $0.00 with a market capitalization of 883 . Over the past 52 weeks, RTSL has traded between $0.00 and $0.01 , with the current price positioned at approximately 0% of this range . The sto...
Key Takeaways
- Operates in the Healthcare sector (Medical - Devices)
- Market cap: 883
- Current price: $0.00
- 52-week range: $0.00 - $0.01
- P/E ratio: 0.01
Investment Score
A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.
Score unavailable for this asset.
0-39
Defensive posture
40-54
Mixed / wait for confirmation
55-69
Constructive setup
70-100
Attractive zone
Total Score
Value
Cheapness vs fundamentals and cash generation
Quality
Durability of profitability and balance sheet
Momentum
Price trend strength and persistence
Company Overview
Rapid Therapeutic Science Laboratories, Inc. (RTSL) is a biotechnology firm specializing in the aerosolized delivery of non-psychoactive cannabinoids directly into the bloodstream. This innovative approach is aimed at treating various conditions, inc...
Company Information
- CEO
- Donal R. Schmidt Jr.
- Sector
- Healthcare
- Industry
- Medical - Devices
- Employees
- 3
Contact Information
- Website
- https://www.rtslco.com
- Address
- 5580 Peterson Lane
- Country
- US
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
✓ Valuation metrics suggest potential value opportunity (P/E: 0.0)
✓ Lower volatility stock (Beta: -1.86) may provide portfolio stability
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for Rapid Therapeutic Science Laboratories, Inc. shareholders
- ⚠Market volatility can significantly impact stock price, especially for smaller companies
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for Rapid Therapeutic Science Laboratories, Inc.
- ⚠Investors should consider how Rapid Therapeutic Science Laboratories, Inc. fits within their overall portfolio allocation
- ⚠Valuation metrics suggest potential, but require fundamental analysis
Market Cap
883
P/E Ratio (TTM)
0.01
Beta
-1.86
Data Sources & Methodology
Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.
Related Stocks
Compare RTSL with peer companies:
- Price
- $0.00
- Market cap
- 1.64K
- Price
- $1.01
- Market cap
- 22.77K
- Price
- $0.00
- Market cap
- 21.52K
- Price
- $0.00
- Market cap
- 23.82K
- Price
- $0.00
- Market cap
- 11.97K
- Price
- $0.00
- Market cap
- 17.66K
- Price
- $0.00
- Market cap
- 2.09K
- Price
- $0.00
- Market cap
- 9.80K
- Price
- $0.00
- Market cap
- 14.99K
- Price
- $8.30
- Market cap
- 18.44K
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.